ClinicalTrials.gov
public full text
Public Domain
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
Dengue fever, caused by dengue viruses, is a major health problem in the tropical and subtropical regions of the world. The purpose of this study is to test the safety of and immune response to a new dengue virus vaccine in healthy adults.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults#869995
- Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine#966151
- Tetravalent Chimeric Dengue Vaccine Trial#882175
- Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS#863444
- Erratum: Discovery of potential antiviral compounds against Dengue virus using virtual screening and physicochemical profiling from zinc database: Erratum: Découverte de composés antiviraux potentiels contre le virus de la dengue par criblage virtuel et profilage physico-chimique à partir d'une base de données sur le zinc#329011
Record · ID 1183766
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive